Company Overview and News

 
A Structural Valuation Of Freeport-McMoRan

2018-09-20 seekingalpha
Freeport operates the Grasberg mine in Indonesia, the second largest copper producing mine in the world after Escondida in Chile.
ANFGF FCX SCCO

2
Rio Tinto announces new US$3.2b share buyback, stock rises

2018-09-20 theedgemarkets
MELBOURNE (Sept 20): Global miner Rio Tinto will return US$3.2 billion to shareholders from its sale of Australian coal assets this year in addition to existing buyback programmes, it said on Thursday.
RTPPF RIO RIO RIO RTNTF FCX WHC

2
Rio Tinto announces new $3.2 billion share buyback, stock gains

2018-09-20 livemint
Melbourne: Global miner Rio Tinto will return $3.2 billion to shareholders from its sale of Australian coal assets this year in addition to existing buyback programmes, it said on Thursday.
RTPPF RIO RIO RIO RTNTF FCX WHC

 
Freeport-McMoRan: Update On Recent Developments

2018-09-17 seekingalpha
Upside momentum should increase once shares are able to get above $15.00 again, with Indonesia deal and copper rebound as potential catalyst.
FCX MS

2
Teck's copper project attracts interest before end-Sept deadline - sources

2018-09-13 reuters
LONDON/TORONTO, Sept 13 (Reuters) - Mining companies and commodities trading houses are expected to table first-round offers by a September 28 deadline for a stake in Teck Resources Ltd’s Quebrada Blanca copper mine expansion in northern Chile, two sources with knowledge of the matter said.
LUNMF FCX AAL LUNCF LUN ZIJMY TECK NSU AAUKF 2899 SSUMF TCKRF NGLOY ZIJMF

3
Freeport-McMoRan Inc. (FCX) Presents at Morgan Stanley 6th Annual Laguna Conference Transcript

2018-09-13 seekingalpha - 1
Freeport-McMoRan Inc. (NYSE:FCX) Morgan Stanley 6th Annual Laguna Conference Call September 12, 2018 4:15 PM ET
RIO RIO FCX RTPPF RIO RTNTF MS

 
Deep Value At Freeport-McMoRan

2018-09-11 seekingalpha
Freeport-McMoRan (FCX) is currently a deep value buy. All of the negative quantitative factors of the firm surround management selling off all of its oil and gas holdings. The sale of the oil and gas holding occurred at a loss. The loss was, however, a rare one-time occurrence that has left the firm in a much stronger place financially. Qualitatively, there is what would appear to be some minor risk associated with the Indonesian government's behavior towards the firm.
FCX

16
Ford, General Motors Drive into Friday’s 52-Week Low Club

2018-09-07 247wallst
September 7, 2018: Here are four stocks trading with heavy volume among 162 equities making new 52-week lows in Friday’s session. On the NYSE decliners led advancers by about 2.14 to 1, and on the Nasdaq, decliners led advancers by about 1.3 to 1.
F AMAT FCX GM

 
Mine for Stronger Risk-Adjusted Profits in Freeport-McMoRan

2018-09-07 investorplace
Off the chart, there remains plenty of reasons, old and new, to be wary of Freeport-McMoRan (NYSE:FCX). But for contrarian-minded bulls, there are now even more technical provisions supporting FCX stock and backing yet another modified fence strategy. Let me explain.
FCX

 
Peru minister proposes making tax benefit for miners permanent

2018-09-06 reuters
LIMA, Sept 6 (Reuters) - Peruvian Energy and Mines Minister Francisco Ismodes on Thursday proposed making a temporary tax benefit for mining companies part of the country’s permanent tax code in order to reduce investment uncertainty in the world’s No. 2 copper producer.
AAUKF FCX AAL NGLOY

 
Freeport-McMoRan: Buy The China Induced Weakness

2018-09-06 seekingalpha
Freeport-McMoRan (FCX) trades near the lows of the last year in the mid-$13 range. The stock generally trades based on the price of copper that recently hit a double bottom around $2.65/lb. The trade discussions with China set up a potential rally in the red metal and the stock of the copper miner.
AAUKF FCX AAL NGLOY

1
Nevsun Resources: Diversified Miner With Minimal Downside

2018-09-05 seekingalpha
The offer undervalues Nevsun Resources and doesn't even take into account the company's Lower Zone assets.
NSU LUNMF FCX LUNCF LUN

10
Is the Options Market Predicting a Spike in Freeport-McMoRan (FCX) Stock?

2018-09-04 zacks - 1
Investors in Freeport-McMoRan Inc. (FCX - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 21, 2018 $8.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other.
TSNU FCX TSN ADBE

60
Tracking Carl Icahn's Portfolio - Q2 2018 Update

2018-09-03 seekingalpha - 3
This article is part of a series that provides an ongoing analysis of the changes made to Carl Icahn’s 13F portfolio on a quarterly basis. It is based on Icahn’s regulatory 13F Form filed on 08/14/2018. Please visit our Tracking Carl Icahn’s Portfolio series to get an idea of his investment philosophy and our previous update for the fund’s moves during Q1 2018.
VLTCP CQP CVI SDRPQ FCX TPCA VMW ENZN AFNL HRI NWL EGN VLTCW CI WBT VKSC ARII LNG GLPI SD XRX IEP NAV CNDT SDOCQ HLF UAN DVMT ERI CVRR VLTC MTW SDRXP HTZ SDRXQ

13
Gold Mining Bull: Top News For August 2018

2018-09-01 seekingalpha
Coeur Mining made a move to buy a heap leach gold deposit in Nevada; Northern Star goes to Alaska for its next mine.
RIO RIO GTBDF KGI.DB NST FCX BFDRF GSV NSU BFD RTPPF MUX.RTWI RTNTF MUX GG KL SAND SSL SDDXF KGI MUX KGI.DB.A CDEUW NULGF SNXZF PSPGF NESRF CDE RIO GBR NHRNY

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to FCX / Freeport-McMoRan Inc. on message board site Silicon Investor.

Freeport McMoran (FCX) Freeport McMoran (FCX) Freeport McMoran (FCX) McMoRan Exploration Co. (MMR) McMoRan Exploration Co. (MMR) McMoRan Exploration Co. (MMR)
Electric Fuel (efcx) Comments Electric Fuel (efcx) Comments Electric Fuel (efcx) Comments AFC Cable Systems (AFCX) AFC Cable Systems (AFCX) AFC Cable Systems (AFCX)
CUSIP: 35671D857